• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A method for stabilizing a physiologically active substance produced by recombinant DNA technique, which comprises adding an albumin to an aqueous solution or powder containing the physiologically active substance, and a stable aqueous solution or powder which contains the physiologically active substance and an effective amount of an albumin, said physiologically active substance having cytotoxic activity against L-M cells and being capable of inducing hemorrhagic necrosis of transplanted Meth A sarcoma in the BALB/c mouse. The aqueous solution or powder containing the physiologically active substance can be stored for a prolonged period of time without losing its activity, and is stable on freezing, thawing, lyophilization or the like.
    公开号:SU1607690A3
    申请号:SU853918201
    申请日:1985-06-06
    公开日:1990-11-15
    发明作者:Сакамото Хадзиму；Киета Такао；Итох Хиратака；Хаяси Хироси
    申请人:Асахи Касеи Когио Кабусики Кайся (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to protein engineering, in particular to the stabilization of tumor necrosis factor obtained by genetic engineering.
    A method for stabilizing a physiologically active compound comprises adding albumin to an aqueous solution or containing tumor necrosis factor (TNF), wherein said physiologically active compound is obtained using recombinant DNA encoding tumor necrosis factor, which has a cytotoxic effect on L-M cells and is able to cause
    hemorrhagic necrosis of 3ALB / C mice transplanted with Meth A. sarcoma
    The tumor necrosis factor is obtained by the usual method of recombinant DNA
    using recombinant DNA encoding a physiologically active compound. When tested, TNF shows a cytotoxic activity against L-M cells and causes hemorrhagic necrosis of MethA sarcoma transplanted in BALB / C mice, TNF is characterized by the following amino acid sequence.
    W
    O5 o
    O5
    Ser Ser Ser Arg Tlir Pro Ser Asp Lys Pro Alaggle GluAl Gly Lea Gin Lea Trg Lea Asparag Arg Ala Asp Ala Alu Lea Leu Ala Asn Gly Glu Gly Leu Tyr Leu He Tyr Ser Gin Val
    Leu Phe Lys Gly Gly Gly Cys Pro Ser Thr His Val Leu Le Thr

    O4
    31607690 4
    His Thr He Ser Arg Lie A Ser Val Cr Gin Thir Lys Ar Gin Thr Glu Ala Glu Ala Lys Pro Tr Gy Lys Gly Asp Arg Lea Alu Alu Glu Asn Arg Pro Asp Tyr Alu Lea Asp Argl Alu Glu Ser Gly Gin Val Tyr Phe Gly He He Ala Leu a DNA fragment encoding M10 has the following structure:
    TCA TCT TCT CGA ACC CCG AGT GAC AAG CGT GTA GCg CAT GTT GTA GCA AAC CCT CAA GCT GAG GGG GAG CTC CAG TGG CTG AAC CGC CGG GCC AAT GGC CTC CTG GCC AAT GGC GTG GAG CTG AGA GAT AAC CAG CTG GTG GTG CCA TCA GAG GGC CTG TAC CTC ATC TAC TAG CAG CTC TTC AAG AGC GGC CA GGC TGC CGC TCC ACC CAT CAT GT CTC CTC ACC ACC ATC CTC AGC CGC ATC GTC ATC CAC ACC TCC TCC ATC AAG AGC CTC CGC AGG GAG ACC CCA GAG GGG GCT GAG GTC AAG CCC TGG GATG CCC ATC TG CTG GGG GTC GTC TAG CAG CTG GAG AAG GGT GGA CGA CTC AGC GCT GTP CGG AAT CGG GAC TAT CTC GTC TTG GTC GAG TCT GG CG GGG PBX ATT GCC CTG,
    This polypept is given the following: L / person selected for hybridization.
    with the help of 32 P-labeled K-DIK kroTkan pancreas of human TNF.
    ka or rabbit is ground to extinct 3. From the corresponding kyons of the extracted powder, deprotected, 4, DNA is harvested, its restriction is compiled, and as a result of osteoproduct, a card is obtained and analyzed by a hybridized molecular molecule rabbit or human rabbit by Sautheres,
    chesky DNA; high molecular DNA derived from hydrolysis
    partially cleaved; DNA restriction fragment fragments containing
    fractionated in size and injected by the yutgens of rabbit or human
    a fragment with a size of 15,000–20000 parfNO, subcloned into a plasmid vector base (on); the fragments obtained and then determined in them last in the preceding stage, the cloning of the bases, using the phage vector T A. The sequence of the bases
    Charon 4A; get a library of DNAs to rabbit TNF c-DNA compare
    human or rabbit in phage. with a sequence of bases in he1. In the c-DNA of rabbit TNF, administration of rabbit TNF was introduced and the exo-radioactive label 32 was determined by the method and introns in the gene for rabbit CPS. translation.5. After this sequence
    2. Each of the genomic bases of the human TNF gene bacteriophage / rabbit and bacteriophage is compared with the sequence
    rabbit name and gene names for exons and introns of the human name.
    6. Confirm that the amino acid sequence of the rabbit name, calculated from the base sequence, obtained by removing the introns of the rabbit gene name in its combined exons, is consistent with the amino acid sequence calculated from the base sequence k-DIK of the rabbit name.
    7. Next, the amino acid sequence of the physiologically active compound used in the invention is calculated from the DIC base sequence encoding the physiologically active compound obtained by removing the introns of the gene encoding the physiologically active compound and connecting its exons. The amino acid sequence of the physiologically active compound is confirmed to be partially consistent with the amino acid sequence of the rabbit name.
    8. Afterwards, the encoding physiologically active compound is modified at the ends in vitro to introduce the appropriate expression vehicle and to obtain recombinantly DIC containing the encoding DNA. The recombinant DNA is used to transform a host cell which, in turn, can grow in culture and express the desired physiologically active compound.
    9. The physiologically active compound thus obtained in its full form has 155 amino acid residues starting with serine. If it has a signal peptide in its precursor sequence, then this signal peptide is highly hydrophobic.
    The transformed organism thus obtained is cultivated on a wide scale in the usual way with the production of TNF. After this, the culture supernatant or cell extract is collected and TNF is obtained.
    The resulting TNF is purified using either conventional biochemical techniques to produce an aqueous solution of TNF, which is
    ten
    five
    20
    25
    thirty
    35
    0
    P
    The filament is dried and the powder is purified by full name. Purification of TNF is carried out by salting out using ammonium sulphate, ion exchange chromatography using anion exchange resin, gel filtration and electrophoresis.
    Albumin is added to the solution in an amount of approximately 1 µg or more, preferably 10 µg or more, particularly preferably 100 µg or more, per 1 ml of a solution having a cytotoxic activity with respect to LM cells equal to 10 -10 units / ml (unit activity will be determined below). The upper limit of the amount of an albumin is usually determined by its solubility and the viscosity of the resulting solution. The upper limit of the amount of albumin is usually 50 or 10 mg per 1 ml of the full name. If the full name is stabilized in powder form, then albumin is added to the powder in such an amount that an aqueous solution obtained by dissolving the powdered physiologically active compound is added. and having an activity units / ml, had the above concentration of albumin.
    The manner in which albumin is added does not play a significant role. For example, albumin in powder form can be directly added to the solution of the active compound. In addition, powdered albumin, for convenience, can be dissolved in water or a suitable buffer and added to the solution. Albumin powder can also be mixed with the active compound powder. The addition of albumin can be carried out at any time during the purification stage or the stage of preparation of pharmaceutical formulations.
    Calf Thymus DNA / SS PE: 0.13 M NaCl + 10 mM NaH, P04. + G mM EDTU, pH 7.4.
    The SHF is a phage storage medium containing 5.8 g of NaCl, 2 g of MgS04 7HB, 50 ml of 1 M tris-IC (pH 7.5) and 5 ml of a 2% gelatin solution per liter.
    Cr-Broth: Medium containing 10 g of 5 NZ-amine, 5 g of NaCI and 2 g of MgS04 7H O (NZ-amine is an AM type casein hydrolyzate, produced by gH and supplied by Humko Sheffield Chemical Durnon of Kraft, Gnc. CFIA).
    five
    IPTG: isopropyl thiogalactoside. x-gal: 5-dibromo-4-chloro-3-indolyl-helactoside,
    Pelvis; 0.04 M Tris-acetate (pH 8.0) 0.002 M EDTU.
    5 X Denhardt solution: an aqueous solution containing 1000 mg of Ficoll, 1000 mg of polyvinylpyrrolidone and 1000 mg of BSA in 1 liter.
     a couple of reasons.
    Example: A rabbit with a mass of 2.5–3 kg, 50 mg of those killed by Pepionebacterium acnes (Corynebacterium parvura, Wellcome Research Laboratories England) were injected into the ear vein by injection into the ear vein. After 8 days, 100 µg of endotoxin was administered again through the ear vein ( dipolysaccharide from Escherichia coli 026: B6, manufactured by Difco Laboratories, QM, after 2 h, whole blood is taken from the heart, To the obtained blood, sodium heparinate is added in an amount of 100 units per 100 ml. Then the blood is centrifuged while cooling at a rate of 5000 rev / min for 30 min to remove blood cells and insoluble solid compounds. As a result, and 40 rabbits receive plasma (2.4 l) having a ditotoxic activity of the serum full name equal to 3x10 units / ml,
    24 g of zeolite was added to the plasma (2.4 l), the resulting mixture was stirred for 1 hour, then filtered, the filtrate was mixed with 1.2 l of 0.04 M Tris-HCl buffer (pH 7.8) and sediment t per column with DEAE-Spharose CL-6B, carefully balanced against 0.04 M Tris-HC1 buffer (pH 7.3) containing O, 1 M NaCl, The column is washed with 0.04 M Tris-HC1 buffer and adsorbed full name 0.04 M Tris-HC1 buffer (pH 7.2) containing 0.18 M NaCl. Fractions exhibiting cytotoxic activity against L-cells are concentrated by ultrafiltration. The concentrate thus obtained is applied on a column with Sephacryl S-200, carefully balanced against 5 mM phosphate buffer, and subjected to gel filtration using the same 6yii) epa. Active fractions are concentrated by ultrafiltration and get Purified FULLY having an activity of 3, units, and a specific activity of 18x10 ed, / mg,
    Rabbit serum FIO is mixed with Freund's full stimulator
    0
    g 5 about
    Q 5
    five
    (1: 1) and subcutaneously injected into the back of male Ba LB / C mice that are aged
    2 weeks. The above operation is repeated 2 and 4 weeks after the initial injection. 1 week after the last injection, whole blood is collected. Serum is obtained from selected blood.
    The serum thus obtained is added to the culture medium to evaluate the cytotoxic activity of the full name against L-cells in such an amount that the resulting concentration corresponds to 500-fold dilution. The cytotoxic activity of the rabbit serum full name against the L-cells is measured as described above. Rabbit serum FIO is not established to exhibit cytotoxic activity against L-cells. From this result, it can be concluded that serum obtained at this stage contains an antibody to rabbit serum FIO (hereinafter referred to as anti-TNF antibody),
    The formalin-killed Propionibacterium acnes cells (Corynebacterium parvum, Wellcome Research Laboratories, England) were injected intravenously into rabbit by intravenous injection. After 7 days, the rabbits were subjected to trisystomy, the lungs were washed with physiological saline, and thus cells were splashed with physiological saline. saline; Using RPM1 1640 culture medium containing 10 vol% fetal bovine serum; Cells are incubated at 37 ° C in air containing 5% carbon dioxide. The cell culture is divided into two groups and endotoxin obtained from E, coli (lipopolysaccharide from E, coli 026: B6) is added to one of them, at a concentration of 10 µg / ml. The same amount of distilled is added to the other group. water, a cell culture supernatant to which endotoxin has been added, exhibits cytotoxic activity against L-cells, and the activity reaches a maximum within 7 hours. This activity is inhibited by anti-TNF antibody, but not inhibited by normal min serum,
    In addition, the cell culture supernatant, to which endotoxin was not added, does not show cytotoxicity against L-cells.
    Radioactive L- / 35S) -Me tonin (1300 curie / mmol, in the amount of 1 millicuri / ml) is added to the cell culture to which endotoxin is added. The supernatant is analyzed by electrophoresis on a polyacrylamide gel with LTOs in accordance with the Laemmli method. The gel concentration is adjusted to 12.5% by weight. After electrophoresis, the gel is treated with ENHANCE and, after drying, exposed to x-ray film. It is established that in a cell culture supernatant in the presence of endotoxin, a compound is formed which has a molecular weight of about 17,500.
    The supernatant of each cell culture is subjected to electrophoresis on a polyacrylamide gel with LTOs in the same manner as described above. After that, the gel is shaken in 2.5% W 40® for 1 hour and then in water for 2 hours. After sticking, each migration strip is cut out and cut into strips 2 mm wide in the direction perpendicular to the migration direction . Each strip is cultured with L-cells and cytotoxic activity is evaluated for L-cells. In the band where the supernatant of the cell culture containing endotoxin was micro-plated, cytotoxic activity against L-cells is found at a position corresponding to a molecular weight of 17,500. In other positions, no cytotoxicity is detected.
    Inaccurate culture is incubated at. 2 hours after the addition of endotoxin, then centrifuged and the cells are harvested. Extraction of cytoplasmic RNA from harvested cells, extraction of mRNA is carried out from cytoplasmic RNA. K 3x10 cl. 4 ml of a 4 M guanidine thiocyanate solution are added and the mixture is ground with a homogenizer. The residues are removed by centrifugation and dissolved in a mixture of 2.4 g of cesium chloride. The mixture is carefully inserted into a polyallomer tube, to which 2.5 ml of a solution containing 5.7 M cesium chloride and O, 1 M EDTA (pH
    7.5), and then subjected to ultracentrifugation at 30,000 rpm for 12 hours at. After the supernatant was added, the pellet was dissolved in 1 ml of 10 mM Tris-HC1 buffer containing 5 mM EDT and 1% May / vol% SDS. The resulting solution is extracted with chloroform: 1-butanol (4: 1 by IQ volume). 0.05 volumes of 2 M sodium acetate and 2.5 volumes of ethanol are added to the aqueous phase and allowed to stand at 20 ° C for 2 hours or longer, resulting in 15 RNA precipitating 15. The precipitate is collected by centrifugation, dried and dissolved in 500 µl of sterile water. The result is a solution of cytoplasmic RNA. The resulting RNA solution is heated to 20 at 63 ° C for 2 minutes and then rapidly cooled. To the solution, 500 µl of 1 O mM Tris-PIDT buffer of two-fold concentration (pH 7.4) was added, the mixture was applied to 200 mg of oligo-dT-5 cellulose packed in a column, and washed with 10 ml of the same buffer (single concentration ). The compound remaining in the column was eluted with 2 ml of elution buffer containing 0 O mM Tris-HCl buffer (pH 7.4), mM EDTA and 0.1 May / v / v% SDS. 0.05 volume of sodium acetate and 2.5 volumes of ethanol are added to the eluent and the mixture is cooled at -20 s to form a precipitate. The precipitate is collected by centrifugation, applied to a column of oligo d-T-cellulose, and the fractions adsorbing on oligo-e-T-cellulose are collected. 85 µg m-RNA is isolated, as shown by the analysis of the ultraviolet spectrum.
    330 µg of RNA is dissolved in 250 ml of water, and the resulting solution is applied in a layer on 10 ml of a 5-25% linear sucrose density gradient. The sucrose density gradient is obtained using Tris buffer solutions containing 25 mM Tris-HCl (pH 7.2), 2 mM EDTA, 1 May / vol.% LTO and respectively: 5 and 25% sucrose.
    five
    0
    55
    Ultracentrifugation was performed at 40,000 rpm for 12 hours at 4 ° C and fractions, each having a volume of 400 µl, were collected using an fraction extraction apparatus, followed by ethanol precipitation. The precipitated fractions were centrifuged and dissolved in sterile water.
    eleven
    The m-RNA is translated using Xenopus laevis oscites. Fractionated m-RNA is dissolved in 13 sterile water to obtain a concentration of 1 µg / µl and a solution of entering 13 societies in a small amount (50 or id, cell). The cells are then cultured for 24 hours in Barca solution (contains 7.5 Tris-HCl, pH 7.6, 83 mM NaCl, 1 mM KCl, 0.33 mM calcium nitrate, 0.41 mM calcium chloride 0.82 mM magnesium sulfate , 2.4 mM sodium bicarbonate, 18 U / ml penicillin G and 18 µg / ml streptomycin) containing bovine serum albumin at a concentration of I mg / ml. Oscites are ground in culture medium with a glass rod. After that, the culture fluid is centrifuged and the supernatant is tested for cytotoxicity against L-cells, m-RNA, translated to obtain a polypeptide with maximum activity, according to sedimentation analysis, has a size of 16S. Activity is inhibited by anti-TNF antibody.
    Using 5 μg of fractionated m-RIK, double-stranded DNA is obtained. Double-stranded fractions were measured on a 3.5% polyacrylamide gel and 530 g of the ug fraction was obtained, having a size of approximately 1000-2000 bp. 7 ng of this fraction is extended with deoxy-C residues using terminal deoxynucleotide transferase, renatured with 56 ng of plasmid pBe 322, which is digested with PstI, and extended with lezoxy-G residues. The renaturated grandchild is thus injected into the E.coli K-12 stamp (HBI01, ATCC 33694) to transform the strain; B, 12000 transformed organisms are obtained.
    Rabbitous name is subjected to electrophoresis on a polyacrylamide gel with decyl sulfate Na for cleaning. Frequently, the gel is colored with Coomassie brilliant blue. The band at the site corresponding to a molecular weight of 17,000 is cut out from the gel and extracted with a 1% ammonium bicarbonate solution. Approximately 130 µg of the full name are extracted as a protein.
    . 150 µg of the selected name are dissolved in 75 µg of a 1% bicar-solution (ammonium zonate, after which it is added












    0
    1 2 TRNC.
    are 3 μg trypsin TRNC. The mixture is incubated for 4 hours. Thereafter, the mixture is fractionated with
    high pressure liquid chromatography on a column yields fragments split with trypsin.
    The name of the high degree of purification and its trypsin-cleaved fragments are desalted on a column with Sephadex-25, and then freeze-dried. Purified name and trypsin-cleaved fragments are subjected to Edman decomposition from the N-terminus. Each detachable amino acid at each stage is analyzed in the usual way using a high pressure chromatograph model SP3100. As a result, it is established that the full name has the following N-terminal amino acid sequence: Ser-Ala-Ser-Arg-Ala-Leu-Ser-Asp-Lys-Pro-Leu-Ala-His-Val-ValAla-Asn-Pro-Gln- Val-Glu-Gly-Glu-Leu-Gln-,
    One of the cleaved by trypsin fragments has a decrepit amino acid sequence:
    Glu-Ths-Pro-Glu-Glu-Ala-Glu-Pro-MetAla.
    Oligododexinucleotides, complementary to the base sequence of m-RP K, calculated from the amylic acid sequence of the rabbit name, are synthesized in accordance with the improved phospho-ethereal method. In the preparation of oligodeoxynucleotides, 28 oligodeoxynucleotides calculated from the amino acid sequence
    rabbit name, are classified according to five groups, namely groups 16, 16, 32, 32 and 32, and synthesized as mixtures of oligodeoxynucleotides of the corresponding groups, C obtained
    oligodeoxynucleotides of the respective groups are deprotected in the usual way and they are purified by column chromatography on Sephadex-50 by electrophoresis on a 20 wt.% polyacrylamide gel containing 7 M urea and column chromatography using E52. Oligodetoxynucleotides of the corresponding groups thus obtained are subjected to dialysis.
    against a buffer solution of 0.1 Tris-EDTU,
    A radioactive label was introduced into each of the purified oligodeoxynucleotides of the respective groups using T4 polynucleotide kinase and 32P-adenosine triphosphate by a known procedure and then purified by column chromatography using DE52. The radioactive compound is introduced into each of the nucleotides of the respective groups in the amount of
    clearly 3x10 counts / min per 1 µg.
    The m-RNA of the cells that produce the full name is treated with a solution containing M glyoxal, 10 mM and 50% by volume of dimethyl sulfoxide for 60 t-nm and then fractionated using 1.1% by weight electrophoresis agarose gel. The fractionated m-RNA is transferred to an electrophoretic filter to produce prints. After that, the m-RCA on the filter is treated with a solution of 5 x Denhardt solution containing 5 X SSC solution, 0.75 M NaCl + 0.075 5 sodium citrate, -PH 7. 150 µg / ml denatured salmon spermatozoon DNA, for 2 h and then treated with a solution of 5 x Denhardt solution, containing 1x10 imp / min per 1 ml of labeled oligodeoxynucleotides, and a solution of 5 x SSC, for 2 hours. The filter thus obtained is washed with a solution of 6 X SSC (0.9 M Had + 0.09 M sodium citrate), pH 7, four times, successively at room temperature, 40, 50 and. Oligodeoxynucleotides designated as Ml probe are found to be most strongly permeable to m-RNA, indicating that oligodeoxynucleotide having a base sequence completely complementary to m-RNA is contained in the oligodeoxynucleotide designated Ml. The DNA of the transformed organisms hybridize with the labeled oligodeoxynucleotide (sample Ml). 49 colonies were selected that strongly hybridized with labeled oligodeoxynucleotides (sample Ml) and then fixed on another nitrocellulose filter. After that, using 49 colonies, further hybridization is carried out and 9 colonies most strongly hybridized with labeled oligodeoxynucleotides (sample Ml) are selected.
    From 9 colonies receive approximately 5 μg of plasmids. Each of the resulting plasmids was digested using restriction enzymes.
    25
    07690
    PstI, TaqI, Rsal and PvuII. After that, the fragments obtained by cleavage with the help of appropriate restension enzymes are compared taking into account their length.
    The results show that all nine strains corresponding to nine colonies have a base sequence of the fragment cleaved by PvuII and Rsal and consist of approximately 50 bp, and that most of the 9 strains contain the base sequence of the fragment J5 cleaved Rsal and consisting of about 200 bp. The results indicate that the strains have a partially identical base sequence.
    The seven strains containing the plasmids listed in Table 1 are separately cultured in 2 ml of LB medium containing 10 µg / ml of tetracycline until the optical density of the solutions reaches the values shown in Table 1, after which centrifuging is carried out and appropriate strains are obtained. Each of the obtained strains is separately added to 30 2 ml of physiological saline solution and sonicated. The solutions obtained are centrifuged and op-. The cytotoxic activity of the resulting supernatants against L-j cells is determined. The results are presented in-tab. In an empty experiment are reproduced: the above procedure using a strain containing the plasmid pBR 322.
    40 Cytotoxic activity against
    L-cells are inhibited by anti-TNF antibody, but not inhibited by normal mouse serum. This indicates that all nine of the above indicated colonies have plazuids containing oligodeoxynucleotides encoding the full name. E. coli strains containing plasmids pB 2-7 and pR 13 are cultured in 1 liter of M9 medium containing 10 μg / ml 0 of tetracycline. Plasmids are recovered in an amount of approximately 150 µg.
    The base sequence of each plasmid insert is determined by the Maxam-Hilbert chemical method. 5 Thus, you remove the full sequence of rabbit name.
    At this stage, a plasmid is constructed using a recombinant plasmid pR 12 with direct expression of the full name in 11 using lac as a promoter. The first 10 µg of plasmid pR 12 is cleaved with 10 units. Ara I for 2 hours and subjected to electrophoresis on 4% by weight polyacryl amide gel, fragments with a length of 610 bp. Electrolytically, approximately 1 µg of the fragments are separated from the gel by electrolysis.
    Two oligodeoxynucleotides are synthesized; З -GATCCATGTCAGCTTCTCGGGCC- З and 5 -CGAGAAG CTGACATG3. After that, each 5-terminus of oligodeoxy nucleotides (approximately 100 picol) is phosphorylated using T-polynucleotide kinase. After completion of the reaction, the reaction mixture is extracted with phenol and then chloroform. Then, the resulting synthetic oligomers are mixed with 0.5 µg of APA of a 1-fragment, 630 bp long, and planted with ethanol. The fragments were coupled with synthetic oligomers at 4 ° C overnight using 10 units. T4.-LNK-ligase. After completion of the reaction, the reaction mixture is precipitated with ethanol and 20 units of BamHI are split at 37 ° C for 3 hours, after which electrophoresis is carried out at 4 wt. polyacrylamide gel and electroelution were isolated fragments of a length of 670 PsO, 1 μg of commercially available
    plasmids RS-3 are digested with
    BamHI, extracted with phenol, then chloroform, and then precipitated with ethanol and get the vector. 0.5 µg of the resulting vector is linked using T-DNA ligase to form a fragment having BamHI sites at both ends and containing approximately 670 base pairs encoding the full name. E. coli Ml O is transformed using the vector obtained above and cultured on agar medium containing 1 mM IPTG and 0.004 (May / vol) x-gal to obtain approximately 200 white colonies. Plasmid DNA is obtained from 100 of these transformed organisms and is digested with liamHI. As a result, 15 plasmids are found to contain, as expected, a BamHI fragment (about 670 bp). In order to verify the insertion direction 15, the indicated plasmids were cleaved with Eco RI having one single recognition site in pUC-8 and RTOI, which has only one recognition site in

    0 5 0
    five
    about 5 Q
    fragment length of approximately 670 base pairs, and subjected to electrophoresis on a 6 wt.% polyacrylamide gel. As a result, it is established that 7 plasmids have, as expected, a fragment consisting of approximately 140 bp, and that the transcription direction of the lac promoter on pUC-8 is consistent with the transcription direction of oligodeoxynucleotides encoding the full name.
    DNA sequence analysis shows that 7 plasmids have the same sequence and contain the desired nucleotide sequence in the transitions between the lac promoter, synthetic DNA and c-DNA.
    The construction of other plasmids was carried out using recombinant plasmid pR17 to obtain direct expression of the full name in E. coli using lacUV 5 as a promoter. First, 10 µg of the plasmid pR 17 cleaves 10 units. Apal at 37 ° C for 2 hours, subjected to electrophoresis on a 4% by weight polyacrylamide gel and fragments containing approximately 630 were isolated. Approximately 1 µg of fragments were electrolyzed from the gel. Two oligodeoxynucleotides are synthesized: 5- AATTCATGTCAGCTTCTCGGGCC-3 and CGAGAAGGTGACATG-3. After that, each of the 5 endings of these two oligodeoxynucleotides (approximately 100 pmol) is phosphorylated using T-polynucleotide kinase. Upon completion of the reaction, the reaction mixture is extracted with phenol and then with chloroform. Next, the synthetic oligomers are mixed with 0.5 μg of the previously obtained plasmid pR 1 7 and the Apal fragment precipitated with ethanol (approximately 630 bp). The fragment is bound to synthetic oligomers overnight using 10 units. T-ligases. After completion of the reaction, the reaction mixture was precipitated with ethanol, 20 units were split. EcoRI at 37 ° C for 3 hours and then electrophoresis is carried out on a 4 wt.% Polyacrylamide gel and the fragment is electrically electrolyzed (approximately 670 p, o).
    1 µg of pOP95-15 is cleaved with EcoRI, extracted with phenol, then with chloroform, and then precipitated with ethanol and the vector is obtained. WITH
    1 7
    using T-LIK ligase, 0.5 µg of the obtained vector is linked to a fragment (about 670 bp), obtained by binding a synthetic oligonucleotide to an oligonucleotide encoding the full name. IM101 SATCC 33876) was transformed using the vector obtained above and cultured in medium containing 1 mM IPTG and 0.004% (May / vol) x-gal, to obtain approximately 150 small colonies. Plasmid DNA was prepared from 100 of these colonies and digested with EcoRI. As a result, it is established that 12 plasmids contain the putative EcoRI fragment (approximately 670 bp). To check the direction of insertion, 12 of the above plasmids were digested with PvuII and PstI and subjected to electrophoresis on a 1.5 wt.% Agarose gel. As a result, four plasmids were found to contain target fragments (approximately 1230 bp and approximately 2600 p .o.) and that the direction of transcription of the lac UV5 promoter is consistent with the direction of transcription of oligodeoxynucleotides encoding the full name.
    Ana-: shz sequence of baseline shows that these four plasmids have the same sequence and that the lac UV5 promoter, synthetic oligodeoxynucleotide, and c-DNA are combined in a corresponding manner
    The number of mice completely cured from the tumor
    The number of mice used for the test
    The results are presented in table 2.
    Example 2. Colonies of E. coli K12 strain MC1061 are transformed with plasmids pR 18, pB 2-7 and pE 2-2. A colony of strain MSUB E. coli cultiviru-. in the LB medium until the optical density of the culture broth at 550 nm reaches a value of 0.3.50 ml of the grown E.coli culture is collected, washed with 25 ml of a mixture containing 10 MOP (pH 6.5) and 10 mM RbCl, and re-suspended in 25 ml of a mixture containing O, 1 M MOPS (pH 6.3), 50 mM CaClij, and 10 mM RbCl. The resulting suspension is cooled on ice for 30 min, centrifuge076901
    melt with each other. The resulting plasmids are termed rfno lac UV 5-1.
    5 E.coli strains containing plasmids were cultured in 50 ml of LB medium containing ashycillin at a concentration of 100 μg / ml, overnight. The strains are then transferred to 5 liters of 10 LB media containing ampicillin at a concentration of 100 µg / mp, and further cultured for 3 hours. Isopropyl-p -B-thiogalactopyranosnums are added to it as a result of a 15% concentration. mM Cultivation is continued for another 6 hours, after which cooling is carried out. Then the strains are collected by centrifugation. Add 5 liters of a buffer solution of 0.04 and Tris-HCl (pH 7.8) to 5 liters, sonicate and obtain a protein solution. The resulting solution has a cytotoxic activity against L-cells, equal to 25 5x107 units / l.
    The resulting solution is purified in the same way and get 1.2x10 units. FULL NAME. The specific activity of the full name is 6.8x10 units / mg.
    30 Sample (0.2 Ml) TNF is tested by an in vivo assay method.
    20 days after the injection of the sample, an examination of the degeneration of tumors is done and the proportion recovered by the following formula is calculated.
    . 2 ml of D5 above mentioned mixture containing 0.1 M MOPS (pH 6.5), 50 mM CAC1, 10 mM RbCl and 30 μl DMSO are suspended and suspended in a mixture. To an aliquot of the resulting suspension with a volume of 200 µl, 10 µl 50 of each of the solutions of the plasmid DIC were separately added. Each of the resulting mixtures is cooled on ice for 30 minutes and then heated at 44 ° C for 60 seconds. Immediately thereafter, J5 to each of the heated mixtures was added 5 ml of preheated LA C medium to 31 ° C, after which incubation was carried out at 37 for 1 hour. Each of the resulting cultures 19
    broths are centrifuged with b-forming cell sludge. The supernatant is discarded, LB medium is added and each cell pellet is suspended by stirring. Each of the resulting suspensions was plated onto a BL-1 agar plate containing tetracycline at a concentration of 30 μg / ml and then incubated with overnight. As a result, colonies of transformed organisms resistant to tetracycline are obtained, each of which is transformed with plasmids pR 18, pB 2-7 and pB 2-2.
    Transformed strains with plasmids RB 2-7 and pR 18 are subjected to the following operations: growing the transformed organism, collecting and lysing the transformed organism, and purifying the plasmid DNA according to the method. Each of the transformed strains was seeded in LB medium and incubated with vigorous shaking. This step is repeated to grow the transformed organism and amplify the plasmid. The culture of the transformed organism is harvested by centrifugation at AOOOg for 10 minutes at. The supernatant is discarded. The resulting precipitate is washed with 100 ml of ice-cold NTE (0.1 M Had, 10 mM Tris-HC1, pH 7.8, and 1 mM EDTA) and lysed by boiling using 20 mg / ml lysozyme in 10 Tris-HC1 pH 8.0 The viscous product is transferred to an ultracentrifuge tube and centrifuged at 25,000 rpm for 30 minutes while obtaining a DNA solution. Measure the volume of the DNA solution. For each milliliter, exactly 1 g of solid cesium chloride is added and gently stirred until the salt has completely dissolved. For every 10 ml of cesium chloride solution, 0.8 ml of ethyl bromide solution (10 mg / ml aqueous solution) is added. The resulting solution density is 1.55 g / ml, and the eipoMHCToro ethyl concentration is approximately 600 µg / ml. The cesium chloride solution is transferred to a centrifugation tube and the remaining portion of the tube is filled with light paraffin oil. Centrifugation is carried out at 45,000 rpm for 36 hours and two DNA bands are obtained, where the upper band consists of 0769020
    bacterial and labeled circular plasmid DNA, and the lower band consists of a closed circular plasmid DNA. The lower DNA band is collected into a glass tube using a hypodermic needle inserted through a side wall.
    test tubes. Ethyl bromide is removed and the aqueous phase is dialyzed against a pelvis. The plasmid DNA solution is treated with RNAase and extracted with an equal volume of phenol. The aqueous phase layers are applied to the column equilibrated with the TAZ (pH 8.0) and 0.1% DSNDNA in the column is washed and deposited with TE with 0.1% SDS to collect fractions. Fractions precipitated with ethanol and receive pure plasmid DNA. 20 According to the above procedure, 250 μg of pure plasma DNA rB 2-7 and 134 μg of pure DNA of plasmid pR 18 are obtained.
    The pB 2-7 plasmid DNA (40 µg) was cleaved with PstI restriction enzyme and subjected to electrophoresis on a 4% acryl amide gel. After electrophoresis, the DNA is stained and the desired band is cut out to obtain the PstI insert.
    30 Using a 500 g of the isolated PstI insert, translation was performed with a label and 80 pmol of radioactive dCTP was added to 25 µl of the reaction system (at 400 curie / mmol). To a mixture consisting of 2.5 µl of Solution A (dNTP solution), 2.5 µl of Solution B (500 ng of the test DNA, namely PstI inserts); 5 µl of dCTP labeled (3200 curie / mmol), 1.3 µl of dCTP without Q label (65 pmol, 50 pmol / µl dCTP), 11.2 µl of solution E (water), a total of 22.5 µl, add 2, 5 µl of the solution with DNA-base 1, DNA-polymerization 1 and conduct the reaction at 15 ° C for 60 minutes. Thereafter, to terminate the reaction, t-RNA, re-precipitated with ethanol and dissolved in 500 µl of water, is added as a carrier to the resulting mixture. 5Q The ideal activity per 1 μg of DNA is 9.3x10 counts / min.
    The operations described above are also repeated with pure plasmid pR 18 DNA for translation with a label. The specific activity of 1 µg of ravg DNA at 7x10 min / min.
    30 μg of plasmid pR 18 DNA is digested with restriction enzyme Rsdl and subjected to polyacrylamide electrophoresis.
    35
    45
    gel. The bands of the target inserts indicated below are cut out and purified on a column: approximately 640 p, o., 3.77 µg (yield 52%), approximately 175 bp, 1.77 µg (yield 50%),
    The above insert, having about 640 bp, is referred to as a 3-fragment of pR 18 (corresponding to the 3-untranslated region of pR 13), and the above approximately 175 p. Of this is designated as pR 13-cfr (corresponding to the coding section of pR 18).
    In addition, the above operations are repeated using PstI and Mstll restriction enzymes instead of Rsdl and the following band is obtained: approximately 450 bp, 3.65 µg (60% yield) This insert is designated as the 3 fragment of pR 18.
    The labeled P insertion plasmid pB 2-7 is used as a hybridization test to select 10 negative colonies of the bacteriophage Gharon 4A (human genomic library, n6-derived by inserting fragments of certain sizes of partially digested human DNA into E.coRI). ). At the same time, the method of hybridization of negative colonies is used. Since not all of the bacteriophage in the original culture contains the necessary genetic material for obtaining the full name of a person, a sample having a base sequence complementary to the rabbit full name gene is used. DNA of phage negative colonies containing the desired genetic material and a radioactive label are identified by the displayed radioactivity. 9 hybridized negative colonies were isolated from the kit.
    The following methods and conditions are used:
    1. The number of negative colonies: about 1x10 (colonies. About 4x10 colonies per dish with a diameter of 150 mm),
    2. Transfer using citrocellulose filters.
    3. Hybridization: addition of 1.25 X 10 ipm / min "ml of sample insertion pB 2-7, 19.5 h.
    4. Protectors: 2 x SSC (0.30 M NaCl + 0.030 M sodium citrate, pH 7) - 0.1% sodium dodecyl sulfate at room temperature. Immersion X 4; 1 x SSC (0.15 M LaC1
    20
    + 0.015 M sodium citrate, pH 7) - 0.1% sodium dodecyl sulfate at - immersion 30 min X 2.
    5 5. Exposure: for XAR-5 X-ray film, 2 reinforcing screens, 39 h.
    As a result of the above selection, 12 potential 10 candidate strains were obtained. Using . The described selection method involves the second selection stage, as a result of which 9 strains containing the required fragment were obtained. Then, using the indicated strains, the third stage of selection is carried out 15, resulting in 9 stramones containing the indicated fragment. Using these strains containing the indicated fragment, a fourth stage of selection is carried out, intended to confirm that the 9 strains contain the required fragment . The resultant selection of 9 bacteriophages containing the desired fragment was designated HG-I and HG-9, respectively.
    The I0 negative colonies of the Cliaron 4A bacteriophage 4A / rabbit genomic combination are used, which are obtained by using the splitted rabbit DNA, instead of the splitted human DNA. At the same time, 6.7 X 10 negative colonies of the Charon bacteriophage (the rabbit genomic library instead of 10 negative colonies of the Charon bacteriophage 4A) of the human genomic library are used. Two strains of bacteriophage 0 (designated PG-I and PG-2) are obtained. ; Happering TNF gene of the rabbit genome.
    Bacteriophage DNA HG-3, HG-6 and HG-7 are obtained,
     E cells, coli LE-392 (host cell 5) are suspended in 18 ml of phage storage medium and 3x1 units of U are added to it. negative colony formations of bacteriophage HH-3, resulting in infection with 0 E. coli for 20 minutes with. Then, 3 L of N-broth is added to the mixture and cultured with shaking for 23 hours with; 60 ml of chloroform, after which the culture is continued to shake for 30 minutes. Sodium chloride is then added to the mixture, bringing its concentration to a final value equal to IM, after which the mixture
    ten
     . 1607690
    leave for 15 min., centrifuged to remove the upper layer. Thereafter, polyethylene glycol (molecular weight about 6000) is added to the mixture in such an amount that the concentration of polyethylene glycol is 10% (May / vol), and again it is left for 22 hours at. Bacteriophages are harvested after centrifugation. The resulting bacteriophages are suspended in 28 ml of phage storage medium and an equal volume of chloroform is added to the suspension, the penny. After stirring for 30 seconds, the reaction mixture is centrifuged, resulting in an aqueous phase. The phage storage medium is added to the indicated aqueous phase to a total volume of 30 cent. To the resulting mixture, 26.4 g of cesium chloride was then added, which was carefully dissolved, after which the mixture was subjected to an ultracentrifuge (45000 rpm, 20 h) to obtain the bacteriophage as a separate layer. The resulting mixture containing bacteriophages is dialyzed using 10 mK sodium chloride solutions — 50 mM Tris (hydroxymethyl) aminomethane (Tris buffer) pH 8 10 mM magnesium chloride. After that, EDT, proteinase K and sodium dodecyl sulfate are added to the mixture in such quantities that their concentrations are 20 mM, 50 µg / ml and 0.5% (May / vol), respectively, then the mixture is treated at for I h, then extracted with phenol, a mixture of phenol and chloroform (1: 1 by volume) and then with chloroform.
    24
    . DNA: HG-3 325 iq kaad 935 ng each; HG-7 685 ig
    2. cleavage with the use of various restriction enzymes BauHI; 10 items EcoRI; BamHI; 10 items EcoRI; 10 items 10 items Hindlll; 10 items EcoR PVU; temperature Zus, prod)
    20
    3. electrophoresis: 0.8% ag gel, TAE, 23 V, 15.5 4J
    4.transfer to the filter from n lulose:
    5.Prevender hybrid 30 ml FDNH, 42 ° C, 6 h;
    6..hybridization: 5-fragments 1x10 imp / min / million pR 18, the temperature is 42 I :, continue for 14 h;
    7. flushing: 2 x SSC - 0, sodium cisulphate at room temperature: immersion 4x10 m
    X SSC - 0.1% dodecyl sulfate 25 at 50 ° C: immersion 2x30 mi
    8. Winch: X-ray XAR-5, 2 amplifying devices
    14 h.
    The results of the hybridization of p 30 in the table.3.
    35
    Bacteriophages R RG-2 are used instead of each of the bactes HG-3, HG-6 and HG-7. As a result, the 5 pR 18 fragment is coded with the fragments or fra contained in one layer, cleavage of both RG-2, and the enzyme enzyme as a result of cleavage.
    we get, „„ „, .o„ in „„ „ia, /,:,„ Ba-G E oRlTiinrHb. m
    LYZED WITH APPLICATIONS. “. niuuiil
    lysed using a solution of 10 mM Tris buffer (pH 8) - 1 m1-1 EDTA. Ultraviolet absorption measurements for the resulting aqueous phase indicate that pure bacteriophage DNA is obtained.
    The same operations and in the same sequence as described in the case of obtaining bacteriophage HG-3 DNA are carried out with the aim of obtaining bacteriophage HG-6 and HG-7 DNA.
    The result is 2920 μg of HG-3, 1100 μg of HG-6 and 819 μg of HG-7.
    The obtained DNA was analyzed by the Southern spot method. The technique and conditions for its implementation are as follows:
    BamHI + EcoRI.
    5.33 μg obtained with. This HG-3 is cleaved with 80 u. EcoRI at flow
    45 The cleavage product is subjected to rophoresis using a 1% low melting agar gel.
    Sing with 2.9 Kb allocate
    5Q level gel A part of the gel, a layer of 2.9 kb, was heated for 15 minutes. Cleaved EcoRI fragment of HG-3, having 2.9 T. p. (subsequently the wagon train
     The washed HG-3 / EcoRI-2.9 T.O.-fr is separated from the melt of the gel in the mouth of a threefold extractant with nol and threefold extrag and ethanol, followed by precipitation.
    0
    690
    24
    . DNA: HG-3 325 iga caad; HG-6 935 ng each; HG-7 685 each:
    2. cleavage using various restriction enzymes: 0 units of BamHI; 10 items EcoRI; 10 items BamHI; 10 items EcoRI; 10 items Hindlll; 10 items Hindlll; 10 items EcoRI; 10 items PVU; ZUS temperature, long-)
    0
    3. electrophoresis: 0.8% agar gel, TAE, 23 V, 15.5 4J
    4.transfer to nitrocellulose filter:
    5. Pre-hybridization: 30 ml FDNH, 42 ° C, 6 h;
    6 .. hybridization: 5 -fragment 1x10 imp / min / million pR 18, conditions: temperature 42 I :, duration 14 h;
    7. washing: 2 x SSC - 0.1% sodium dodecyl sulfate at room temperature: immersion 4x10 min; 1 x
    X SSC - 0.1% sodium dodecyl sulfate 5 at 50 ° С: immersion 2x30 min
    8. Top: XAR-5 X-ray film, 2 reinforcing screens.
    14 h.
    The hybridization results are shown in Table 3.
    Bacteriophages RG-i and RG-2 are used instead of each of the bacteriophages HG-3, HG-6 and HG-7. As a result, the 5 pR 18 fragment is found to be hybridized with the fragments or fragment contained in one layer, obtained by cleaving RG-1 and RG-2, and each of the enzymes:
    Va-G E oRlTiinrHb. m
    , “Va-G E oRlTiinrHb. m
     “. niuuiil
    and
    BamHI + EcoRI.
    5.33 μg obtained with. this HG-3 DNA is cleaved using 80 units. EcoRI for 3 hours
    45 The cleavage product was subjected to electrophoresis using a 1% low melting point agar gel.
    Sing with 2.9 Kb isolated from aga5Q smooth gel. A portion of the gel containing a 2.9 kb layer was heated at 15 minutes. The EcoRI-cleaved HG-3 fragment, having a length of 2.9 kb. (subsequently designated HG-3 / EcoRI-2.9 T. O. fragment), was separated from the melt of the gel as a result of three-time extraction with phenol and three-time extraction with ethanol, followed by precipitation
    25
    ethanol containing ammonium acetate. As a result of the operations noted above, 637 ng of HG-3 / EcoRI-2.9 TPO fragment is obtained (yield about 30%).
    255 ng of the fragment obtained according to the method described above is bound to 6.5 ng of EcoRI-cleaved pUC-13 using 2.5 units of T4 ligase at 4 ° C and a processing time of 20 hours.
    The transformation of E. coli K-12, strain IM-33, was carried out using the binding product obtained as described above. E.coli K-12, strain IM-83, is cultivated in Dourier-Bertani medium until the optical density of the culture broth becomes 0.3 at 550 nm, 50 ml of the grown culture E. coli K-12, strain IM -83, collected, washed with 25 ml of a 10 mM solution of morpholinopropanesulfonic acid (pH 7.0 with 10 mM of rubidium chloride, and resuspended in 25 ml of a solution of 0.1 M of morpholinopropanesulfonic acid (pH 6.5 with 50 mM calcium chloride - 10 mM chloride rubidi. The suspension is cooled in ice for 30 minutes, centrifuged and re-suspended in a mixture of 2 ml of O, IM morpholinopropanesulfone acids (pH = 6.5) - 50 mM calcium chloride - rubidium chloride and 30 µl of DXCO. 10 µl of an aqueous solution of the binding product containing 10 ng of the binding product is added to 203 µl of the suspension. The mixture is cooled in ice for 30 minutes and then heated to 60 s. Immediately thereafter, 5 ml of Lurie-Bertani medium, preheated to 37, are added to the heated mixture, after which the incubation is carried out at 37 ° C for 1 h. the broth is centrifuged and the upper layer is removed. After this, the medium is added Bertani to the obtained cell concentrate and inoculate on a Lurie-Bertani medium containing 30 μg / ml ampicillin and 40 μg / ml X-galactoside. Colonies containing E. coli K-12, strain IM-33 transformed with plasmids containing inserts, are white, then kak colonies containing E. coli K-12, strain IH-33 transformed only with plasmids, have a blue color. The resulting colonies
    0769026
    The white color is inoculated again on Lurie-Bertani medium plates containing 30 µg / ml ampicillin and 40 µg / ml X-galactazide to confirm the result.
    From the white colonies obtained according to the described method, 10 colonies (bacterial clones) are selected, Q, which are subjected to selection using a micropreparative technique. Each colony is cultured overnight in medium containing 30 μg / ml ampicillin. Growing cells are harvested and suspended in a solution containing 2 mg / ml lysozyme - 50 mM glucose - 10 m - EDTA - 25 mM Tris-HCl buffer (pH 3.0). The suspension is left at room temperature 20 for 5 minutes, after which 200 µl of 0.2 N is added. sodium hydroxide - 1% sodium dodecyl sulfate. After slow stirring, the suspension is left at room temperature for 2 minutes. After that, 150 µl of 3 M sodium acetate solution (pH 5.2) is added, the mixture is left at -20 C for 10 minutes, then centrifuged for 15 minutes, thus removing the upper layer of liquid. 900 µl of cold ethanol is added to this upper layer, then centrifuged for 10 minutes, resulting in a precipitate. The resulting pellet is washed with 70% ethanol and dried, resulting in plasmid DNA. Using the method described above, 10 plasmid DNAs are obtained.
    Each LNA plasmid was dissolved in a solution of 10 mM Tris buffer -0.1 mM EDTA (pH 3.0), digested with EcoRI and subjected to electrophoresis for restriction analysis. The conditions for the cleavage and electrophoresis are as follows: the splitting-solution of the LNA plasmids 1: 5 part of the amount obtained; EcoRI: 3 units, S7, 1.5 h; electrophoresis - 1% agar gel, 5Q 1xTAE, 120 V, 2 h.
    35
    40
    45
    55
    The above restriction analysis shows that 3 clones out of 10 are positive. This means that these 3 clones contain a fragment from 2.9 kb. Of the eight positive clones, one clone is chosen, designating it as E.coli. K-12, strain IM-83 (pH Ge) (ATCC 39656).
    27, 1
    The same operations in the same sequence as in step 2 described above are repeated to obtain 1.39 mg of DNA, the pH of HU, except that E. coli, K-12 strain III-E3 are used ( pHGE), instead of E. coli with a pB 2-7 pR 18 treatment, I 30 µg of RG-1 was digested with E.coRI. From the resulting mixture of fragments, a fragment having a length of about 3.5 kb is separated. using exactly the same method as described above for stage 9, except for using the obtained mixture of fragments in advance and 0.8% agar gel with a low melting point, 3 the result is 1.0 μg of a split EcoRI fragment PG-1 (3.5 thousand p.). The PG-1 fragment (3.5 p. O) obtained by the EcoRI-cleaved method described above is associated with the EcoRI-digested pUC-13, except that the previously obtained EcoRI-cleaved fragment (3.5 thousand. HG-3 (2.9 thous. Pp.).
    E. coli K-12 strain IM-83s is transformed with bacterial clones, splitting clones and electrophoresis, except that the binding product obtained according to the described method is used. The resulting clone is designated E. coli K-12, strain IM-83 (pRGe) (ATCC 39655). Operations are repeated to obtain 1.70 mg of pRGE DNA, except that instead of pB 2-7 and pR 18, E is used. .coli K-12, strain IM-83 (pRGE).
    Restriction enzymatic analysis of pHGE DNA was performed.
    The following one-way radios and conditions are used:
    1. DNA cleavage of pHGE by means of EcoRI 18.6 μg HHKpHGE, 64 units of EcoRI, 2 h;
    2. ethanol precipitation: a precipitate is used;
    3. addition of distilled water to the sediment - obtaining a solution of EcoRI-cleaved pHGB with a concentration of 1 μg / ml;
    4. cleavage with various restriction enzymes:
    1 μg / ml of EcoRI-cleaved pHGE; restriction enzymes: 5 units, PvU |
    0769028
    11.5 units PvuII + 10 units. Rsal, 10 units. Rsal, 4 units. Mst, 11.3 units. Aval, 9 units. PstI,, 2 h;
    5. Electrophoresis: 2% agar gel, 1xTAZ, 23 V, 14.5 h;
    6. transfer to nitrocellulose filter;
    7. first pre gibri10
    35
    Dispensation: 30 ml PDNH, 42 ° C, 6 h;
    3, first hybridization: 5-fragment of 5x10 imp. in min / ml pR 18 42 ° C for 14 h;
    9. flushing: 2 x SSC - 0.1% solution
    J.5 sodium dodecyl sulfate at room temperature - 4 dives for 10 min; 1 X SSG - 0.1% solution of sodium dodecyl sulfate at 50 ° C - 2 immersions for 30 minutes.
    20 O- exposure: X-ray film
    XAR-5, 2 effort) screen, 17.5 hours;
    11. washing 0.5 M NaON - 1.5 M NaCl: immersion 1 min, 0.5 M Trisbufer-2, 5 M NaCl: immersion 1 min,
    25 ЗхННЦ - immersion of mines;
    12. Exposure is performed;
    13. the second pre-hybridization;
    14. Second hybridization: insert
    30 PH 2-7, 16.5 hours;
    15. flushing;
    16. Exposure with the exception that the holding time is 19.5 hours;
    17. washing;
    18. Exposure, except that the holding time is 20 hours;
    19.three pre-hybridization;
    20.thre hybridization: Z -frag-. Ment (4.5x10 min per min / ml pR 13),
    , 15h;
    21. flushing;
    22. Exposure.
    Restriction ferd5 enzymatic analysis of plasmid DNA was performed.
    prge.
    The same operations are repeated, except that F, .col: K-12, strain IM-83 (pHGE), and E.coli 50 12, strain IM-83 (pP.GE) are used instead of
    E. coli K-12, MC-1061, with pB 2-7, and E. coli, strain MG-1061 with pp 8, Ta-, Kim method get 150 μg of the plasmid pPGE DNA and the DNA of the plasmid pHGE.
    55
    The sequences based on pPGE and pHGE are determined according to the Kaksam-Hilbert method.
    The pR 18 base sequence is compared to the pRGE base sequence, determined according to the above method for the elucidation of the structure, including the exon and the intron gel of the rabbit's full name. Then the pRGE base sequence is compared with the pHGE base sequence to investigate the homology and consistency of the sequence in the region of the border between the intron and the exon.
    Obtained as described
    above, the sequence method is essentially jc connected.
    RTSAGCT TSTCGG GCC CTG AGT GAC AAG ССТ СТА GCC САС GTA GTA
    NTSATST TSTCGA ACC CCG AGT GAC AAG CCT GTA GCC CAT GTT GTARGCAAAC CCGCAA GTG GAG GGC CAG CTC CAG TGG CTG AGC CAG CGT
    HGCAAAC CCTCAA GCT GAG GGG CAG CTC CAG TGG CTG AAC CGC CGG
    RGCGAAC GCCCTG CTG CGC AAC GGC ATG AAG CTC ACG GAC AAC CAG
    , HGCCAAT GCCCTC CTG GCC AAT GGC GTG GAG CTG AGA GAT AAC CAG
    RCTGGTG GTGCCG GCC GAC GGG CTG TAC CTC PBX TAC TCC CAG GTT
    HCTGGTG GTGCCA TCA GAG GGC CTG TAC CTC PBX TAC TCC CAG GTC
    R CTCTTC AGGGGT CAA GGC TGC CGC TCC ... TAC GTG CTC CTC ACT
    HCTCTTC / AGGGC CAA GGC TGC CCC TCC ACC CAT GTG CTC CTC ACC
    RCACACT GTCAGC CGC TTC GCC GTC TCC TAC CCG AAC AAG GTC AAC
    HCACACC ATC AGC CGC ATC GCC GTC TCC TAC CAG ACC AAG GTC AAC
    RCTCCTC TCTGCC PBX AAG AGC CCC TGC CAC CGG GAG ACC CCC GAG
    HCTCCTC TCTGCC PBX AAG AGC CCC TGC CAG AGG GAG ACC CCA GAG
    RGAG GCT GAG CCC ATG GCC TGG TAC GAG CCC ATC TAC CTG GGG GGC
    H. GGG GCT GAG GCC AAG CCC TGG TAT GAG CCC ATC TAT CTG GGA GGG
    RGTC TTC CAG TTG GAG AAG GGT GAC CGG CTC AGC ACC GAG GTC AAC
    HGTC TTC CAG CTG GAG AAG GGT GAC CGA CTC AGC GCT GAG PBX AAT
    RGAG CCT GAG TAC CTG GAC CTT GCC GAG TCC GGG CAG GTC TAC TTT
    HCGG CCC GAC TAT CTC GAC TTT GCC GAG TCT GGG CAG GTC TAC TTT
    RGGG PBX ATT GCC CTG
    HGGG PBX ATT GCC CTG
    Into a stainless steel reactor with a working volume of 500 µl and stainless steel filters on each side, 20 Mg of polystyrene resin are introduced, to which nucleoside (2.0 µM) is bound by succinate binding. The resin is treated with zinc bromide (1 M) in a mixture of dichloromethane and isopropanol (35:15) long. udale
    coding the name of the person and the name of the rabbit are given below. The base sequence in the upper row is the base sequence encoding the name of the rabbit (R), and in the bottom row is the base sequence coding for human TNF (H), where the symbol ..... means that this part of the DNA base sequence the rabbit TNF coding is zero and, therefore, the two codons adjacent to this symbol on both sides are directly
    nor dimethoxytrityl protecting groups, washed successively with dimethylformamide, pyridine and acetonitrile, and then dried under a stream of nitrogen. A solution of the nucleotide with dimethoxytrityl groups (dat-nucleotide) (20 µM) and 60 µM mesitylenesulfonylnitrotriazole in 200 ml of pyridine is added to the dried resin.
    The coupling reaction is carried out for 20 minutes at. This cycle of deprotection and coupling is repeated for successively taken nucleotides until the desired oligodeoxynucleotide of the desired type
    1) 5 -AATTCATGTCATCTTCTCGAACCCCGAGTGACAA-3
    2) 3 -GTACAGTAGAAGAGCTTGGGGCTCAGTGTTGGG-5
    3) 5 -GGCTGTAGGCCATG rTGTAGGAAACCGTGAAGG-3
    4) W -ACATCGGGTACAACATCGTTTGGGAGTTGGAGT-S
    10 µg of the pHGE plasmid is cleaved by 20 units. E.coRI. After electrophoresis on a low melting point 1% agar gel, a fragment of 2.9 kb in length was eluted. This fragment is introduced into the E.coRI fragment on the replicative form of phage M-13 gar-9. Phage tr9 is selected because it is particularly well suited for holding portions of DNA. The product is translated into E.coli IM-103. The resulting product is designated Ml 3 mp9-HGE.
    Get single-stranded DNA M-13 np9-HGE ..
    The oligodeoxynucleotide H-ACATGGGG TACAACATCGTTTGGGGTTCGACT-5, prepared as described in step 14, is used as an intron-3 selector. The intron-3 selector is designated EZ-4.
    The EZ-4 divider has a base sequence that is complementary to the base sequence before (exon 3) and after (exon 4) intron 3, which is to be deleted. Intron 3 deletion is carried out as follows.
    EZ-4 (164 ng, 15 pmol) phosphorus irutotes using T4 kinase (10 units) and ATP (3 mM) and added to the matrix M-13 mp9-HGE (1.65 µg, 0.5 pmol) . The reaction mixture is heated for 10 minutes, cooled to room temperature for 5 minutes, and finally cooled in ice-water. To aATP, dGTP, dGTO, atTF and ATP (0.4 mM), add Klenow (5 units), T4 ligase (10 units) in Hin buffer 10 mM Tris-HC1 buffer (pI 7.2) , 2mM of magnesium chloride and 1 mM of p-mercaptoethanol. Reaksv zan with pitch. The resin is then treated in such a way as to remove the oligodeoxynucleotide, and purified.
    The result is the following oligodeoxynucleotides:
    0
    five
    0
    five
    0
    five
    0
    five
    the incubation mixture (final volume 50 μl) is incubated for 30 min at 4 ° C, and then for 30 min at room temperature. DNA temperature, obtained by the reaction of the main oligonucleotide, is used for transfecdia E.so-- 11 IM-103. The resulting colonies were transferred to UT plates. The resulting colonies hybridized at 55 ° C for 2 h
    but§
    With labeled R EZ-4. For this stage, the Delector is used as a probe for the identification of DNA sequences having a corresponding complementary base sequence after the intron to be deleted. Phage are isolated from those colonies that are hybridized with a delector.
    The resulting phage is placed in a dish, and negative colonies are transferred to UT plates. The clones are left for hybridization at 55 seconds for 2 hours with labeled phosphorus P EZ-4. At the same time, positive clones are obtained, and the phage DNA is sequenced; to select such a phage in which intron 3 is completely deleted. Phage of this kind are referred to as p9-HGEA 3-1.
    The replicative form of tr 9-HGe DZ-1 is cleaved by E.coRI. The EcoRI fragment is digested and cloned into EcoRI, digested with pBR-327, to yield the plasmid pHGE 3-1.
    Construction of the remaining plasmids was carried out using the pHGE U3-I plasmid to obtain a plasmid u.3-i that would be capable of direct expression of the name in E. coli using lacIJV 5 as a promoter. Initially, 10 µg of the pHGE aZ-1 plasmid was cleaved with 10 units of AVal and EcoRI at 37 ° C for 2 hours and subjected to polyacrylamide gel electrophoresis (4% by weight) to isolate the fragments. As a result of electroelution, about 1 µg of the fragment was isolated from the gel. Two oligodeoxynucleotides are synthesized, namely, Z-AATTSATSSSATSTTSTSSAASS-3 and 5 -TCGGGGTrCGAGAAGATGACATG-3. Then, the 5-terminus of each of these two oligodeoxynucleotides (approximately 100 pmol) is phosphorylated using a T4 polynucleotide kinase. After completion of the reaction, the reaction mixture is extracted first with phenol and then with chloroform. Then, the synthetically obtained oligomers obtained by the method described above are mixed with 0.5 μg of the previously obtained using IO unit of 14 ligase in accordance with the Aval-EcoRI fragment of the pHGE DZ-1 plasmid and precipitated with ethanol. These fragments are bound overnight with. After completion of the reaction, the reaction mixture is precipitated with ethanol, after which polyacrylamide gel electrophoresis (4 wt.%) Is carried out to isolate the indicated fragment by electroelution.
    1 µg of pOp 95-15 is cleaved with F.coRI and extracted first with phenol and then with chloroform, after which it is precipitated with ethanol, thus obtaining a vector. 0.5 µg of the previously prepared vector is linked to the previously obtained fragment using T4 DNA ligase. E. Coli IM-101 (ATCC 33876) is transformed using the vector previously obtained, and then cultured on agar medium containing 1 mM isopropyl tirgalactazide (IPTG) and 0.004 v / v, X-galactazide, resulting in about 100 white colonies .
    Plasmid DNAs are obtained from these transformants and are digested with EcoRI to identify those plasmids that contain the corresponding EcoRI fragment. To investigate the direction of administration, these plasmids were digested with PvuII and Pvul and subjected to agar gel electrophoresis (1.5% by weight) to select plasmids forming fragments of approximately 1280 base pairs and about 260.0 base pairs, which indicates that the direction The transcription of the lac-UV-5 promoter is in accordance with the case of oligodeoxynucleotide encoding DNA.
    Jq j 20 25
    Go Q
    45 with
    35
    five
    Sequence analysis of the bases indicates that these 2 plasmids have the same sequence, and that the lac-UV-5 promoter, the synthesized oligodeoxynucleotide and the DNA are properly linked to each other. The resulting plasmid is designated rChFNO-lacUV 5-2 (pHTHF-lacUV 5-2).
    E. coli containing rcfno-1ac UV 5-2 is cultured on ordinary nutrient medium. Physiological tests of the product on the FIO-activity show the presence of the same activity, which is achieved in the case of the plasmid rcfNo-lacUV 5-1, containing the name-gene of the rabbit when controlled using the 1ac promoter.
    Example 3. Using the pHGE plasmid and oligodeoxynucleotides 1-4, prepared using the procedure, rCFNO-lacUV 5-1 (pHT HF-lacUV 5-1) is obtained.
    E. coli containing rcfno-lacUV 5-2 is cultured in a usual nutrient medium and induced according to known methods. E. coli is then cultured to obtain E. coli cells containing physiologically active substances, which are used according to the invention. Cells are harvested after centrifugation and subjected to lysis treatment under ultrasound irradiation in 1 liter of 0.04 M Tris-HCl buffer (pH 7.8), resulting in a cell extract containing a physiologically active substance. - Cell extract has cytotoxic activity 4 , 5x10 units / l. The specific activity of the active substance in the extract is 3.0 x X 10 u / mg protein.
    Then, the extract is processed on a column filled with DEAE-Sepharose CL-6B, equilibrated relative to 0.04 M Tris-HCl buffer (pH 8.0), and then eluted with 0.04 M Tris-HCl buffer (pH 8.0). The column was washed with 0.04 M Tris-HCl buffer (pH 8.0) and then eluted with 0.04 M Tris-HCl buffer (pH 8.0) containing O, 1 M sodium chloride. The active fractions are collected and concentrated by ultrafiltration, after which a crude solution is obtained containing the active substance having a specific activity.

    4,0x10 u / mg protein. According to the method described above, the crude solution is treated on a column filled with S-200 Sepharyl, equilibrated with respect to 5 Ml-1 phosphate buffer (pH 7.4) containing 0.15 M sodium chloride, after which the gel is removed. filtering using the same buffer. Active fractions are collected together and. concentrated by ultrafiltration to obtain a solution containing a physiologically active substance having a specific activity of 7.0 x 10 U / mg protein. An aliquot of the solution prepared as described above was diluted with 5 mM phosphate buffer (pH 7.4) containing 0.15 M sodium chloride to obtain a solution of physiologically active substance having a cytotoxic activity equal to 120 units / ml.
    Aliquots of bovine albumin, obtained according to the spin method, are added separately to human serum albumin, samples are prepared with a solution having the albumin concentrations given in Table 4. For each of the obtained samples, the residual activity is determined with respect to the samples. for 2, 7 and 30 days at. In carrying out the test described above, a solution of the active substance in which no albumin has been injected is used as a control sample.
    To determine the residual activity, the activity of each of the samples in vivo or in vitro is examined. During an in vitro study of ocTaTO4HyKi, the activity is calculated from the experimental value according to the following equation:



    Residual activity
    f7 - ---- (/) - JJ
    X 100
    where A is the cytotoxic activity of the sample after physical treatment or storing;
    B -; and toxicity of the sample before physical processing or storage.
    In the in vivo study, each sample of the solution is concentrated, reaching a concentration of 20 compared with the initial solution. Then
    ten
    five
    0
    7690
    50
    five
    0
    five
    36
    0.5 ml of each of the similarly concentrated solutions was administered through the tail vein of each of the mice (in groups of 5 animals) infected with tumors. Antitumor activity is examined after 24 hours according to the criteria below.
    PR and M 4, For each of the solutions, the residual activity is determined in relation to: samples that underwent a single or triple freeze cycle, respectively, before and after freezing to -70 ° C, lyophilization and storage at room temperature for 7 days. In carrying out the above test, a solution of the active substance that does not contain albumin is used as a control sample. As for the lyophilized sample, it is dissolved in sterile distilled water, after which the sample is tested for cytotoxic activity. The in vivo or in vitro residual activity of each sample is tested.
    Example5. Human aliquots are added to aliquots separately in various concentrations of the substance, which are well-known stabilizing agents for solutions of common physiologically active substances, in particular, amino acids, metal salts and chelating agents. Each of the resulting solutions is stored for 7 days, after which they are tested for the presence of antitumor activity according to the in vivo test method. The residual activity is determined by the calculation method described above.
    The results obtained are summarized in table.5.
    50
    Formulas
    invented
    and
    A method for stabilizing a recombinant tumor necrosis factor, comprising adding to an aqueous solution containing a tumor necrosis factor, with a cytotoxic activity in relation to L-M cells equal to 10 -10 units / ml, causing hemorrhagic necrosis of the transplanted
    .37160769038
    MethA sarcomas in the VABB / S. kotoka congeners are characterized by the following. The pH is encoded by pHTMF-lacUV 5-2 plasmid, by the sequence “am” O and ™ I
    Ser-Ser-Ser-Arg-Thr-Pro-Ser-Asp-Lys-Pro-Val-Ala-His-Val-Val-Ala-As-Pro-Gln-Ala-Glu-Gly-Gln-Leu-Gln-Trp- Leu-Asn-Arg-Arg-Ala-Asn-Ala-Ley-Leu-Ala-Asn-Gly-Val-Glu-Leu-Arg-Asp-Asn-Gln-Ley-Val-Val-Pro-Ser-Glu- Gly-Leu-Tyr-Leu-The-Tyr-Ser-Gln-Val-Leu-Phe-Lys-Gly-Gln-Gly-Cys-Pro-Ser-Thr-His-Val-Leu-Leu-Thr-His Thr-Ile-Ser-Arg-Ile-Ala-Val-Ser-Tyr-Gln-Thr-Lys-Val-Asn-Leu-Leu-Ser-Ala-Ile-Lys-Ser-Pro-Cys-Gln-Arg- Glu-Tlir-Pro-Glu-Gln-Ala-Glu-Ala-Lys-Pro-Irp-Tyr-Glu-Pro-Ile-Tyr-Leu-Gly-Gly-Val-Phe-Gln-Leu-Alu-Lys -Gly-Asp-Arg-Leu-Ser-Ala-Glu-Ile-Asn-Arg-Pro-Asp-Tyr-Leu-Asp-Phe-Ala-Glu-Ser-Gly-Gln-Val-Tyr-Phe-Gly -Ile-Ile-Ala-Leu- | And the nucleotide sequence
    TCA TCT TCT CGA ACC CCG AGT GAC AAG CCT GTA GCC CAT GTT GTA GCA AAC CCT CAA GCT GAG GGG GAG CTG GAG CGG AG CGGGGGGGGGGGGGGGG GAG GGC CTG TAG GTC ATC TAC TCC CAG GTC CTC TTC AAG GGC CAA GGC TGC CCC TCC ACC CAT GTG CTC CTC ACC

    CAC ACC PBX AGC CGC PBX GCC GTC TCC TAC CAG ACC AAG GTC AAC

    CTC CTC TCT GCC PBX TAT CTC GAC TTT GCC GAG TCT GGG CAG GTC TAC TTT ATC ATG ATC GCC CTG
    human serum albumin solution, mine in the amount of 10 at 50 mg per 1 ml. .
    The number of renaturized p ar bases
    2-2 2-3 2-7 9 12 13 25 322
    400
    800
    1060
    1550
    1400
    1350
    1350
    0
    I
      a 2
    The amount entered by injection is the Assessment of the activity of the samples. The field is called - the number of rabbit mice - after 1 day
    his full name, worked out
    go E.coli, units / mouse user- - + ++ +++ I 20 days
    in data for test- ISiiyS
    2 X 0014 5/5
    Control (physiological saline solution) 5 5000 0/5
    t l 5, -; ; i LI; l 3
    jHLiiii Bug (Rax-j (ProRl pR 13)
    terioflg) K Ra: empr hybridized 1 fragment, etc.,
    J Copen 5End Z


    HG-3 HG-6 11 (7-7 KC-3 H (.; - 6 HG-7 NG, -3 HG-6 HG-7 HG-3 HG-6 HG-7 HG-3 HG-6 HG- 7 HG-3 HG-6 HG-7
    6.7 1:, 2 9.2 2.9 2.4 2.9 2.9 2.9 2.9 2.9 2.9 2.9 9.7 1.1 9.7 2.2 1.9 2, 2
    Note. The symbol “- denotes the hybrid of that“ e of the fragment itself.
    Table 1

    Cytotoxic activity against L cells, units / ml

    35
    ; io
    10 10 15 -ilO 10 10
    0 ° 0.9 0.9
    No (control) - HSA
    HSA
    BSA
    Notes.
    The numbers in the columns for in vitro tests represent the residual activity according to this definition. Numbers in columns, from OS to tests in. vivo, represent the number of
    Table3
    Stabilizing agent
    No (control)
    HSA
    Glycine
    L-lysine
    L-arginine
    L- Glut amino in a
    acid
    Chlorine
    calcium
    Magnesium Chloride
    EDTA
    Table
    1 j Residual
    activity,% storage at for 7 su
    权利要求:
    Claims (1)
    [1]
    Claim
    A method for stabilizing a recombinant tumor necrosis factor, including adding to an aqueous solution containing a tumor necrosis factor, with cytotoxic activity against b-M cells equal to 10 * 2-10 ^ units / ml, causing hemorrhagic necrosis of the transplanted
    37
    1607690
    38
    MEENA sarcoma in mice VAEV / S, which is characterized by the following
    rty is encoded by rTTYR-1aci7 5-2 plasmid amino acid sequence:
    ί
    8r-5r-5r-Arg-Thr-Pro-5r-Azr-Luz-Pro-7a1-A1aHlz-7a1-7a1-A1a-Azn-Rgo-Srn-Ala-S1i-Slu-S1n-EuS1n-Tgr-Bei -Azp-Ag £ -Ag§-Ala-Azp-Ala-Leu-Lei-Ala-Azp-C1-¥ a1-S1i-Lei-Ag-Agh-Azn-S1n-Leе 7a1-¥ a1Pgo-5g-S1i -S1u-lei-tuh-loe-tee-tugh-8eg-С1п- ¥ a1ei-P11e-Luz-siu-s1p-C1u-Suz-Pro-5g-Thr-H13-ua1Lei-lei-T1гг-Нгз-Тгг 11e-5eg-Ag8-11e-A1a-Ua1-5egtug-S1n-T11G , - Luz-7a1-Azp-Eei-Lei-8eg-A1a-11e-Luz5eg-Pro-Suz-S1n-Agg-S1i-Thyr- Rgo-S1i-S1p-Ala-S1i-Alabouz-Rgo-1gr-Tug-S1i-Pro-11e-Tug-Lei-S1u-S1-¥ a1Re-S1n-Lei-Aii-Luz-Slu-Azr-Agh-Ai -8Г-А1а-С1и-11еАзп-Ag§-Pro-Azr-Tug-Lei-Azr-Pye-A1a-S1i-5e-S1uS1n-Ua1-Tug-Pye-S1y-11e-11e-A1a-nuclei idnoy sequence
    TCA test TST CCA ACC SSS AST CAC AAS CCT Cta SSS SAT CTT Cta CCA AAS CCT Caa CCT CAC SSS CAC STS CAC Tss STS AAS SSS SSS SSS Aat SSS STS STS SSS Aat SSS STS CAC STS ASA SAT AAS CAC HUNDRED STS CTC CCA TCA CAC SSS CTC Tas STS PBX Tas Tss CAC STS CTC TTC AAS SSS Caa SSS hush SSS Tss ACC SAT STS STS STS ACC< CAC ACC" PBX ACC SSS PBX sss CTC Tss Tas CAC ACC AAS STS AAS STS CTC TST SSS PBX AAS ACC SSS Tss CAC ACC CAC ACC CCA CAC SSS CCT CAC SSS AAS SSS hush Tat CAC SSS PBX Tat STS CCA SSS CTC TTC CAC STS CAC AAS CCT CAC CCA STS ACC CCT CAC PBX Aat SSS SSS CAC Tat STS CAC ttt SSS CAC TST SSS CAC STS Tas TTT SSS PBX ATT SSS STS
    human serum albumin solution,
    mine in the amount of 10; 50 mg per 1 ml.
    39
    1607690
    40
    Table 1
    Plasmid Numberrenature couplesgrounds Optical density,° δ00 Cytotoxic activityagainst b cells, u / ml pB 2-2 1400 1,369 35 pB 2-3 300 1.605 <10 pB 2-7 1060 1,364 Ζ10 pK 9 1550 1.618 ^ 10 pK 12 1400 1, 453 15 pK 13 1350 1, 438 by PJ 25 '1350 1.514 BY rvp322 0 1.677 Ζ10
    Table 2
    The injection amount of the rabbit TNF produced by E.scop, units / mouse
    The number of mice used for testing
    Evaluation
    sample activity after 1 price
    I Fields recovered after 20 days
    2 x 10 5 5
    Control (physiological saline) 5
    4 5/5
    0/5
    G and G, I and and l 3
    Enzyme Clone (snc- (Test ry 13) ternofag) • size hybridized
    ΐ Koken 5] Horses 3 '
    ZAGON I non-eNS-6NS-7 6.711.29.2 ΒβιηΗΙ NS-3 2.9 NS-6 2.9 EcoR.1 NS-7 2.9 Esoc I NS-3 2.9 NS-6 2.9 NS-7 2.9 ΗίηάΙΙΙ NS-3 2.9 NS-6 2.9 EsOY1 NS-7 2.9 ΗίηόΙΙΙ ns-s 9.7 NS-6 ъ 1 NS-7 9.7 ΙΙτηΙΙ NS-3 2.2 NS-6 1.9 NS-7 2.2
    0.9
    0.9
    0.9
    Note,
    Symbol - m obaena- "
    hybridization of the same fragment.
    1607690 42.
    Table4
    Stabilization Concentrate Example I Example 2 "·· agent mg / kg Storage at 4'C Storage at 4 * C Freezing Storage at room (solution) (solution) (-70 "C) and from- Noah temperature ΐη νΐίΓΟ ίη νίνο taivanne (lyophilized day day ΐη νίίΓο product), days . . one 1P VI of it ΐη νΐνο 0 | 2 1 7one thirty Ί 0 ί 71 s one7! 7 No (cont - - - y. role) ~ - 100 45 14 2 ++ 3 ++ 3 + 2, -2 40 14 35 + 4, -1 H8A 0.1 100 99 95 91 ++ 3 ++ 2 +++ 3, 95 85 92 +++ 3, ++ 2 ++ 1 H8A one 100 98 96 90 ++ 3 ++ 2 +++ 3, 99 95 101 +++ 4 + 1 ++ 2 B8A one · 100 97 93 94 ++ 3 ++ 2 +++ 4, 100 95 97 +++ 3, ++ 2 ++ 1
    Notes. The numbers in the columns relating to the ΐη νΐετο tests represent the residual activity according to this definition. The numbers in the columns related to the tests ΐη. νΐνο, represent the number of mice
    Table 5
    Stabilizingagent Concentration Residualactivity,% storage atflow7 days No (control) - 14 NZA 1 mg / ml 96 Glycine 0.1 K 13 L-lysine 0.1 M ten B-arginine 0.1 M 17 B— Glyut amino in aya acid 0.1 M 15 Chloride calcium 1 mM 14 Magnesium chloride 1 mM 18 EDTA 1 mM ' 12
    类似技术:
    公开号 | 公开日 | 专利标题
    FI86992C|1992-11-10|Process for producing human tumor necrosis factor and plasmid used in the process
    DE69827507T2|2006-03-09|TRIMERIZING MODULE
    KR910002692B1|1991-05-03|Fsh
    JP2740417B2|1998-04-15|Preparation method of human nerve growth factor by genetic recombination
    FI116943B|2006-04-13|A method for producing tumor necrosis factor receptor fusion proteins encoding DNA and a vector
    JP2882775B2|1999-04-12|Human-glia-derived neurite factor
    EP0602688B1|2002-06-19|Methionine free G-CSf from prokaryotes
    JP2004089184A|2004-03-25|Modified protein, modified alpha- and beta- interferon, phosphorylated protein and its homologue, dna sequence, application and use of the same
    CA1341211C|2001-03-27|Mini-proinsulin, its preparation and use
    DE69929805T2|2006-10-26|MODIFIED E.COLI ENTEROTOXIN II SIGNAL PEPTIDE AND MICROORGANISM OF A FUSION PROTEIN EXPRESSED AS A HETEROLOGICAL PROTEIN
    FI98830C|1997-08-25|Process for the preparation of bifunctional proteins
    JPH08228790A|1996-09-10|Dna which codes variant of homo sapiens serum albumin
    JPH083061A|1996-01-09|Composition containing tumor necrosis factor
    SU1630602A3|1991-02-23|Method for purification of recombinant tumor necrosis factor
    DD154022A5|1982-02-17|PROCESS FOR PREPARING HUMAN PRE GROWTH HORMONE
    JPH08508884A|1996-09-24|Macrophage inflammatory protein variant
    US6875589B1|2005-04-05|Mini-proinsulin, its preparation and use
    DE3523634A1|1986-01-09|SS-UROGASTRON GEN, RECOMBINANT PLASMIDE, TRANSFORMERS, THEIR PRODUCTION AND PRODUCTION OF SS-UROGASTRON
    JPH0866194A|1996-03-12|Gene carrying code for human tumor necrosis factor mutein
    SU1607690A3|1990-11-15|Method of stabilizing recombinant factor of tumor necrosis
    DE3419995A1|1985-12-05|GENE TECHNOLOGICAL METHOD FOR PRODUCING HUMAN INTERLEUKIN-2 AND MEANS FOR CARRYING OUT THIS METHOD
    AU617999B2|1991-12-12|A genetic engineering process for the preparation of angiogenins
    WO1988006625A2|1988-09-07|Arginine-depleted human tumor necrosis factor
    SU1614765A3|1990-12-15|Method of producing recombinant plasmide dna encoding human tumor necrosis factor
    DE3005843A1|1981-09-10|GENERAL PRODUCT OF A HIGHER ORGANISM FROM A MICROORGANISM CONTAINING THIS GENE
    同族专利:
    公开号 | 公开日
    HUT37892A|1986-03-28|
    JPS60260522A|1985-12-23|
    DE3581322D1|1991-02-21|
    HU200939B|1990-09-28|
    EP0166996A1|1986-01-08|
    EP0166996B1|1991-01-16|
    KR860000379A|1986-01-28|
    KR930000187B1|1993-01-11|
    EP0166996B2|1994-12-21|
    LT2137B|1993-09-15|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US4447355A†|1982-04-07|1984-05-08|Asahi Kasei Kogyo Kabushiki Kaisha|Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same|
    JPH0375531B2†|1982-08-31|1991-12-02|Asahi Kasei Kogyo Kk|
    JPH0314291B2†|1982-09-28|1991-02-26|Dainippon Seiyaku Kk|US5288852A|1984-03-06|1994-02-22|Dainippon Pharmaceutical Co., Ltd.|Human tumor necrosis factor polypeptides|
    DE3582183D1|1984-03-06|1991-04-25|Dainippon Pharmaceutical Co|DNS ENCODING THE HUMAN TUMORNIC CROSIS FACTOR AND THE HUMAN TUMORNIC CRISIS FACTOR POLYPEPTIDE.|
    US4879226A|1984-04-06|1989-11-07|Asahi Kasei Kogyo Kabushiki Kaisha|Novel human physiologically active polypeptide|
    JP2629000B2|1986-07-18|1997-07-09|中外製薬株式会社|Stable granulocyte colony stimulating factor-containing preparation|
    US5002876A|1986-09-22|1991-03-26|Phillips Petroleum Company|Yeast production of human tumor necrosis factor|
    US5078997A|1988-07-13|1992-01-07|Cetus Corporation|Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP59115496A|JPS60260522A|1984-06-07|1984-06-07|Method of stabilization of physiologically active substance produced by gene recombinant|LV930179A| LV5098A3|1984-06-07|1993-03-10|Tolerance of stabilization of the necrosis of the necrosis of the plant|
    [返回顶部]